Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis
Published in
Cochrane database of systematic reviews, November 2019
Vanessa Piechotta, Tina Jakob, Peter Langer, Ina Monsef, Christof Scheid, Lise J Estcourt, Sunday Ocheni, Sebastian Theurich, Kathrin Kuhr, Benjamin Scheckel, Anne Adams, Nicole Skoetz
Pharmacology, Toxicology and Pharmaceutical Science
8
4%
Psychology
7
4%
Other
28
15%
Unknown
84
44%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2024.
All research outputs
#1,299,791
of 26,794,105 outputs
Outputs from Cochrane database of systematic reviews
#2,510
of 13,278 outputs
Outputs of similar age
#29,790
of 484,667 outputs
Outputs of similar age from Cochrane database of systematic reviews
#38
of 188 outputs
Altmetric has tracked 26,794,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,278 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.0. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 484,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 188 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.
